FOLFOX + ziv-aflibercept adding anti-angiogenic agent to chemotherapy in advanced gastric adenocarcinoma ASCO GI 2016
Daniel Catenacci, MD of The University of Chicago Medicine discusses FOLFOX + ziv-aflibercept adding anti-angiogenic agent to chemotherapy in advanced gastric adenocarcinoma at ASCO GI 2016
Author: ASCOGI2016
Added: 01/26/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 27, 2016 Category: Cancer & Oncology Source Type: podcasts
ASCO GI 2016: Phase II-III trial results T-DM1 in previously treated gastric and GE junction adenocarcinoma
Joel Randolph Hecht, MD of UCLA Health discusses phase II-III trial results T-DM1 in previously treated gastric and GE junction adenocarcinoma at ASCO GI 2016
Author: ASCOGI2016
Added: 01/23/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 23, 2016 Category: Cancer & Oncology Source Type: podcasts
ASCO GI 2016: How did the ToGA trial changed the management of HER2+ gastric carcinoma
Joel Randolph Hecht, MD of UCLA Health discusses how did the ToGA trial changed the management of HER2+ gastric carcinoma at ASCO GI 2016
Author: ASCOGI2016
Added: 01/22/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 23, 2016 Category: Cancer & Oncology Source Type: podcasts
ASCO GI 2016: FOLFOX + ziv-aflibercept placebo adding anti-angiogenic agent to chemotherapy in advanced gastric and GE junction adenocarcinoma
Joel Randolph Hecht, MD of UCLA Health discusses ASCO GI 2016: FOLFOX + ziv-aflibercept placebo adding anti-angiogenic agent to chemotherapy in advanced gastric and GE junction adenocarcinoma at ASCO ...
Author: ASCOGI2016
Added: 01/22/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 23, 2016 Category: Cancer & Oncology Source Type: podcasts
ASCO GI 2016: The future of gastric cancers will be targeted agents including immunotherapy
Manish Shah, MD of Weill-Cornell Medical Center states that the future of gastric cancers will be targeted agents including immunotherapy at ASCO GI 2016
Author: ASCOGI2016
Added: 01/22/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 22, 2016 Category: Cancer & Oncology Source Type: podcasts
ASCO GI 2016: Phase II study of FOLFIRI versus FOLFOX7 in advanced gastric adenocarcinoma
Manish Shah, MD of Weill-Cornell Medical Center discusses the phase II study of FOLFIRI versus FOLFOX7 in advanced gastric adenocarcinoma at ASCO GI 2016
Author: ASCOGI2016
Added: 01/22/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 22, 2016 Category: Cancer & Oncology Source Type: podcasts
ASCO GI 2016: FOLFIRI versus FOLFOX7 will this randomized trial advance the treatment paradigms for advanced gastric cancer
Manish Shah, MD of Weill-Cornell Medical Center, NYC discusses FOLFIRI versus FOLFOX7 will this randomized trial advance the treatment paradigms for advanced gastric cancer at ASCO GI 2016
Author: ASCOGI2016
Added: 01/22/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 22, 2016 Category: Cancer & Oncology Source Type: podcasts
ASCO GI 2016: Does the Asian population differ from the western populations in regards to gastric cancers
Manish Shah, MD of Weill-Cornell Medical Center, NYC answers the question does the Asian population differ from the western populations in regards to gastric cancers at ASCO GI 2016
Author: ASCOGI2016
Added: 01/22/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 22, 2016 Category: Cancer & Oncology Source Type: podcasts
Phase 1b trial of avelumab, an anti-PD-L1 antibody, in advanced gastric or gastroesophageal junction cancer | Dr Hendrik-Tobias Arkenau at ECC 2015
At the European Cancer Congress (ECC) 2015, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute UK, London, UK, discusses a phase 1b clinical trial that evaluated the safety and clinic...
Author: EMJ
Added: 10/02/2015 (Source: Oncology Tube)
Source: Oncology Tube - October 2, 2015 Category: Cancer & Oncology Source Type: podcasts
The Wide-Ranging Role of the Microbiome
What goes in your stomach can influence countless disorders, from cancer to asthma. Dr David Johnson surveys the latest data underlining the ever-increasing importance of a low-fat, high-fiber diet. (Source: Medscape Gastroenterology Podcast)
Source: Medscape Gastroenterology Podcast - September 15, 2015 Category: Gastroenterology Authors: Medscape Source Type: podcasts
The Wide-Ranging Role of the Microbiome
What goes in your stomach can influence countless disorders, from cancer to asthma. Dr David Johnson surveys the latest data underlining the ever-increasing importance of a low-fat, high-fiber diet. (Source: Medscape Allergy and Immunology Podcast)
Source: Medscape Allergy and Immunology Podcast - September 15, 2015 Category: Allergy & Immunology Authors: Medscape Source Type: podcasts
Update 2: Molecular Targets & Novel Agents for Gastric Cancer
Filmed on location in New York during the Great Debates and Updates in GI Malignancies 2015, this webcast is part of a series that provides educational discussions on controversial areas in the manage...
Author: imedex
Added: 09/14/2015 (Source: Oncology Tube)
Source: Oncology Tube - September 14, 2015 Category: Cancer & Oncology Source Type: podcasts
Debate 7: Adjuvant Therapy in Gastric Cancer - Radiation Therapy is Required
Filmed on location in New York during the Great Debates and Updates in GI Malignancies 2015, this webcast is part of a series that provides educational discussions on controversial areas in the manage...
Author: imedex
Added: 08/28/2015 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2015 Category: Cancer & Oncology Source Type: podcasts
Debate 7: Adjuvant Therapy in Gastric Cancer - Radiotherapy Adds Nothing
Filmed on location in New York during the Great Debates and Updates in GI Malignancies 2015, this webcast is part of a series that provides educational discussions on controversial areas in the manage...
Author: imedex
Added: 08/28/2015 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2015 Category: Cancer & Oncology Source Type: podcasts
Pembrolizumab for Advanced Gastric Cancer
Dr, Bang discusses pembrolizumab for the treatment of advanced gastric cancer.
Yung-Jue Bang, MD, PhD, Professor of Medical Oncology, Seoul National University College of Medicine; President, Biomedi...
Author: onclivetv
Added: 07/17/2015 (Source: Oncology Tube)
Source: Oncology Tube - July 17, 2015 Category: Cancer & Oncology Source Type: podcasts
